We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

96 hedge funds and large institutions have $410M invested in Gossamer Bio in 2020 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 11

9% more funds holding

Funds holding: 88 → 96 (+8)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.25% less ownership

Funds ownership: 61.2% → 60.95% (-0.25%)

10% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 30

35% less capital invested

Capital invested by funds: $632M → $410M (-$221M)

70% less call options, than puts

Call options by funds: $1.09M | Put options by funds: $3.66M

Holders
96
Holders Change
+8
Holders Change %
+9.09%
% of All Funds
2.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
27
Reduced
30
Closed
11
Calls
$1.09M
Puts
$3.66M
Net Calls
-$2.58M
Net Calls Change
+$12.3M

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$19.7M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$4.77M
3
Citadel Advisors
Citadel Advisors
Florida
+$3.56M
4
AG
Artal Group
Luxembourg
+$2.61M
5
Morgan Stanley
Morgan Stanley
New York
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$24.1M
2
FCM
Farallon Capital Management
California
-$5.22M
3
Norges Bank
Norges Bank
Norway
-$4.23M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$1.66M
5
Franklin Resources
Franklin Resources
California
-$1.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Russell Investments Group
76
Russell Investments Group
United Kingdom
$48K -$346K -26,481 -85%
UBS Group
77
UBS Group
Switzerland
$41K -$332K -25,447 -86%
Walleye Capital
78
Walleye Capital
New York
$37K +$47.3K +3,626 New
AIP
79
Ameritas Investment Partners
Nebraska
$36K – – –
Zurich Cantonal Bank
80
Zurich Cantonal Bank
Switzerland
$29K – – –
Barclays
81
Barclays
United Kingdom
$10K +$12.5K +960 +10,667%
CA
82
Clearstead Advisors
Ohio
$10K +$13.1K +1,000 New
Canada Life
83
Canada Life
Manitoba, Canada
$9K – – –
Osaic Holdings
84
Osaic Holdings
Arizona
$9K +$12K +918 New
PA
85
Parallel Advisors
California
$9K +$12.1K +929 New
US Bancorp
86
US Bancorp
Minnesota
$8K – – –
EWM
87
Endurance Wealth Management
Rhode Island
$7K +$9.14K +700 New
HDIM
88
Hanson & Doremus Investment Management
Vermont
$5K – – –
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$4K -$72.5K -5,552 -93%
CG
90
Cutler Group
California
$4K -$11.8K -900 -69%
Daiwa Securities Group
91
Daiwa Securities Group
Japan
$4K – – –
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
$2K -$96.2K -7,364 -98%
MF
93
Manchester Financial
California
$2K – – –
RE
94
RBC Europe
United Kingdom
$1.72K +$2.21K +169 New
TFA
95
Toth Financial Advisory
Virginia
$1K – – –
IHAM
96
Integral Health Asset Management
New York
– -$938K -60,000 Closed
ARTA
97
A.R.T. Advisors
New York
– -$827K -52,938 Closed
Rafferty Asset Management
98
Rafferty Asset Management
New York
– -$668K -42,710 Closed
BC
99
Birchview Capital
Vermont
– -$469K -30,000 Closed
FAM
100
Fred Alger Management
New York
– -$469K -30,000 Closed
1 2 3
4
5

GOSS Hedge Fund Activity: Q1 2020 in Review

96 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q1 2020, worth a combined $410M — down 35% from $632M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new GOSS positions and 11 closed out — a net gain of 10 holders — while 27 added to existing stakes and 30 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $19.7M. The largest seller was Omega Fund Management, cutting an estimated $24.1M.

  • 96 institutional investors held Gossamer Bio (GOSS) as of Q1 2020, up from 88 in Q4 2019.
  • Funds reported $410M of Gossamer Bio stock for Q1 2020, down 35% quarter-over-quarter.
  • 21 funds opened new Gossamer Bio positions in Q1 2020 and 11 closed out, a net change of +10 holders.
  • The largest Gossamer Bio buyer in Q1 2020 was Victory Capital Management, an estimated $19.7M added.
  • The largest Gossamer Bio seller in Q1 2020 was Omega Fund Management, an estimated $24.1M sold.

Based on aggregated 13F filings for Q1 2020.